These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cannabis use: signal of increasing risk of serious cardiovascular disorders. Jouanjus E; Lapeyre-Mestre M; Micallef J; J Am Heart Assoc; 2014 Apr; 3(2):e000638. PubMed ID: 24760961 [TBL] [Abstract][Full Text] [Related]
43. Substance use disorder of equimolar oxygen-nitrous oxide mixture in French sickle-cell patients: results of the PHEDRE study. Gérardin M; Rousselet M; Couec ML; Masseau A; ; Aquizerate A; Authier N; Deheul S; Roussin A; Micallef J; Djezzar S; ; Feuillet F; Jolliet P; Grall-Bronnec M; Victorri-Vigneau C Orphanet J Rare Dis; 2024 Mar; 19(1):124. PubMed ID: 38500184 [TBL] [Abstract][Full Text] [Related]
44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
45. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting]. Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408 [TBL] [Abstract][Full Text] [Related]
46. COgnitive enhancement and consumption of psychoactive Substances among Youth Students (COSYS): a cross-sectional study in France. Batisse A; Leger S; Vicaut E; Gerbaud L; Djezzar S Public Health; 2021 May; 194():75-78. PubMed ID: 33865150 [TBL] [Abstract][Full Text] [Related]
47. Health consequences of cocaine use in France: data from the French Addictovigilance Network. Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H; Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152 [TBL] [Abstract][Full Text] [Related]
48. Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data. Roussin A; Soeiro T; Fouque C; Jouanjus E; Frauger E; Fouilhé N; Mallaret M; Micallef J; Lapeyre-Mestre M; Br J Clin Pharmacol; 2022 Aug; 88(8):3789-3802. PubMed ID: 35318713 [TBL] [Abstract][Full Text] [Related]
49. Skin hyperpigmentation: a rare presenting symptom of nitrous oxide abuse. Fang X; Li W; Gao H; Ma Y; Dong X; Zheng D Clin Toxicol (Phila); 2020 Jun; 58(6):476-481. PubMed ID: 31522576 [No Abstract] [Full Text] [Related]
50. [Thirty years of nefopam abuse in France]. Revol B; Delorme J; Jouanjus É; Spadari M; Djezzar S; Lepelley M; Khouri C; Fouilhé Sam-Laï N; Mallaret M; Therapie; 2021; 76(6):527-537. PubMed ID: 33618914 [TBL] [Abstract][Full Text] [Related]
51. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution. Dupui M; Micallef J; Lapeyre-Mestre M Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951 [TBL] [Abstract][Full Text] [Related]
52. [Twenty-five years of the French Addictovigilance Network (FAN)]. Micallef J; Mallaret M Therapie; 2016 Sep; 71(4):375-8. PubMed ID: 27296806 [TBL] [Abstract][Full Text] [Related]
53. Nitrous oxide-induced myeloneuropathy: report of cases. Gutmann L; Johnsen D J Am Dent Assoc; 1981 Aug; 103(2):239-41. PubMed ID: 6943187 [TBL] [Abstract][Full Text] [Related]
54. The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. Myles PS; Leslie K; Chan MT; Forbes A; Peyton PJ; Paech MJ; Beattie WS; Sessler DI; Devereaux PJ; Silbert B; Schricker T; Wallace S; Lancet; 2014 Oct; 384(9952):1446-54. PubMed ID: 25142708 [TBL] [Abstract][Full Text] [Related]
55. Substance use during the COVID-19 pandemic: What is really happening? Mellos E; Paparrigopoulos T Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473 [TBL] [Abstract][Full Text] [Related]
56. [Cathinones use in Paris]. Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479 [TBL] [Abstract][Full Text] [Related]
57. Nitrous oxide abuse in perspective. Gillman MA Clin Neuropharmacol; 1992 Aug; 15(4):297-306. PubMed ID: 1516075 [TBL] [Abstract][Full Text] [Related]
58. French national health insurance database analysis and field study focusing on the impact of secure prescription pads on zolpidem consumption and sedative drug misuse: ZORRO study protocol. Gérardin M; Rousselet M; Caillet P; Grall-Bronnec M; Loué P; Jolliet P; Victorri-Vigneau C BMJ Open; 2019 Jun; 9(6):e027443. PubMed ID: 31256026 [TBL] [Abstract][Full Text] [Related]
59. Just 'nanging' around - harmful nitrous oxide use: a retrospective case series and review of Internet searches, social media posts and the coroner's database. Chiew AL; Raubenheimer JE; Berling I; Buckley NA; Becker T; Chan B; Brett J Intern Med J; 2022 Oct; 52(10):1724-1732. PubMed ID: 34029427 [TBL] [Abstract][Full Text] [Related]
60. [Postoperative dementia: toxicity of nitrous oxide]. El Otmani H; El Moutawakil B; Moutaouakil F; Gam I; Rafai MA; Slassi I Encephale; 2007; 33(1):95-7. PubMed ID: 17457299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]